SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly. The Italian Study of Pharmacological Treatment of Acute Stroke in the Elderly Group.

Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print Cited Medium: Print ISSN: 1590-1874 (Print) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE

Original Publication: Milano, Italy : Springer-Verlag Italia, c2000-

Aged/*physiology ; Aged, 80 and over/*physiology ; Aging/*physiology ; Stroke/*drug therapy; Age Factors ; Aged/statistics & numerical data ; Aged, 80 and over/statistics & numerical data ; Anti-Bacterial Agents/therapeutic use ; Anticoagulants/therapeutic use ; Antihypertensive Agents/pharmacology ; Brain Infarction/epidemiology ; Brain Infarction/pathology ; Brain Infarction/physiopathology ; Disability Evaluation ; Diuretics, Osmotic/therapeutic use ; Female ; Humans ; Italy ; Male ; Patient Selection ; Platelet Aggregation Inhibitors/therapeutic use ; Predictive Value of Tests ; Prognosis ; Risk Factors ; Sex Factors ; Stroke/mortality ; Stroke/physiopathology ; Treatment Outcome

We investigated the clinical outcome and current therapeutic management of ischemic stroke in elderly patients in different neurological wards throughout Italy. Twelve centers in 10 Italian regions were involved. The clinical and instrumental data were prospectively collected for 335 patients 65 years or older, presenting in a 12-months period. At the multivariate analysis, death was associated with the presence of total anterior circulation infarct and the use of antiedema agents. Stroke-related disability was related to female sex, unified stroke scale (USS) scores at entry and mini-mental state examination (MMSE) scores at the 1-months follow-up. The majority of patients (70%) received antiplatelets to prevent stroke recurrence. Very elderly (> or =80 years) patients had worse presentation and prognosis than less elderly stroke victims (<80 years). Age played an important role in the therapeutic approach to stroke: while antiplatelets were widely used, oral anticoagulants were underused even when specifically indicated.

0 (Anti-Bacterial Agents)
0 (Anticoagulants)
0 (Antihypertensive Agents)
0 (Diuretics, Osmotic)
0 (Platelet Aggregation Inhibitors)

Date Created: 20020712 Date Completed: 20020821 Latest Revision: 20071115

20231215

10.1007/s100720200019

12111617